U.S. News examines growing threat of drug-resistant TB

NewsGuard 100/100 Score

U.S. News & World Report examines the growing epidemic of drug-resistant tuberculosis (TB), highlighting a "new paper published earlier this week in the Centers for Disease Control and Prevention's Emerging Infectious Diseases journal warn[ing] that the first cases of 'totally drug-resistant' tuberculosis have been found in South Africa and that the disease is 'virtually untreatable.'" The magazine continues, "Drug-resistant TB isn't just a South African problem," noting "more than 100 cases of [multi-drug resistant TB (MDR-TB)] have been detected in the United States over the past eight years, and there have been high-profile outbreaks in Peru, Russia, and India over the past decade." According to the WHO, "22 'high burden' countries (including South Africa) account for 80 percent of the world's TB cases," with "the organization's most recent report not[ing] that the 'global burden of TB remains enormous,'" the magazine writes (Koebler, 2/11).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The path to a better tuberculosis vaccine runs through Montana